SCD and metabolic dysfunction-associated steatohepatitis: It can be seen that USP7 ensures the full activation of SREBP-1C and its target genes ACC, FASN, and SCD through a variety of regulatory mechanisms, leading to an increase in hepatic de novo lipogenesis and promoting the progression of NASH to cirrhosis and HCC.